SE412755B - Sett att framstella n-metyl-n-(3,4,5-teimetoxibensyl)-2,3-dimetyl-2,4pentadienamin - Google Patents

Sett att framstella n-metyl-n-(3,4,5-teimetoxibensyl)-2,3-dimetyl-2,4pentadienamin

Info

Publication number
SE412755B
SE412755B SE7504301A SE7504301A SE412755B SE 412755 B SE412755 B SE 412755B SE 7504301 A SE7504301 A SE 7504301A SE 7504301 A SE7504301 A SE 7504301A SE 412755 B SE412755 B SE 412755B
Authority
SE
Sweden
Prior art keywords
teimetoxybenzyl
dimethyl
prepare
methyl
Prior art date
Application number
SE7504301A
Other languages
English (en)
Swedish (sv)
Other versions
SE7504301L (sv
Inventor
Jarque R Granados
Cartes J Bosch
Cabiro J Canals
Roldan C Martinez
Peinado F Rabadan
Original Assignee
Made Labor Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Made Labor Sa filed Critical Made Labor Sa
Publication of SE7504301L publication Critical patent/SE7504301L/xx
Publication of SE412755B publication Critical patent/SE412755B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
SE7504301A 1974-05-04 1975-04-15 Sett att framstella n-metyl-n-(3,4,5-teimetoxibensyl)-2,3-dimetyl-2,4pentadienamin SE412755B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES425970A ES425970A1 (es) 1974-05-04 1974-05-04 Un procedimiento para la obtencion de n - metil - n-(3,4,5-trimeboxibencil)-2,3-dimetil-2,4-pentadienamina.

Publications (2)

Publication Number Publication Date
SE7504301L SE7504301L (sv) 1975-11-05
SE412755B true SE412755B (sv) 1980-03-17

Family

ID=8466594

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7504301A SE412755B (sv) 1974-05-04 1975-04-15 Sett att framstella n-metyl-n-(3,4,5-teimetoxibensyl)-2,3-dimetyl-2,4pentadienamin

Country Status (14)

Country Link
JP (1) JPS5337337B2 (enExample)
AR (1) AR206623A1 (enExample)
AT (1) AT337160B (enExample)
AU (1) AU8050775A (enExample)
BE (1) BE828240A (enExample)
CA (1) CA1052794A (enExample)
CH (1) CH615150A5 (enExample)
DE (1) DE2518534A1 (enExample)
ES (1) ES425970A1 (enExample)
FR (1) FR2269336B1 (enExample)
GB (1) GB1501153A (enExample)
NL (1) NL7505254A (enExample)
SE (1) SE412755B (enExample)
SU (1) SU562192A3 (enExample)

Also Published As

Publication number Publication date
FR2269336B1 (enExample) 1977-09-09
SU562192A3 (ru) 1977-06-15
JPS50151835A (enExample) 1975-12-06
FR2269336A1 (enExample) 1975-11-28
DE2518534A1 (de) 1975-11-13
ATA181075A (de) 1976-10-15
CA1052794A (en) 1979-04-17
AU8050775A (en) 1976-10-28
BE828240A (fr) 1975-10-22
AT337160B (de) 1977-06-10
JPS5337337B2 (enExample) 1978-10-07
ES425970A1 (es) 1976-09-16
NL7505254A (nl) 1975-11-06
CH615150A5 (en) 1980-01-15
GB1501153A (en) 1978-02-15
SE7504301L (sv) 1975-11-05
AR206623A1 (es) 1976-08-06

Similar Documents

Publication Publication Date Title
SE413237C (sv) Sett att framstella finkornig, amorf, felld kiseldioxid
SE7512087L (sv) Sett att framstella vattensvellbar polyalkylenoxid
SE7606280L (sv) Sett att framstella etrar
SE7607152L (sv) Sett att framstella nya 2-piperidinoalkyl-1,4-bensdioxaner
SE7505009L (sv) Sett att framstella vetgas.
SE430887B (sv) Sett att framstella vissa substituerade fenylguanidiner
SE7514429L (sv) Sett att laka finfordelad, jernhaltig skersten
SE417507B (sv) Sett att framstella 2-arylamino-2-imidazolinderivat
SE7506687L (sv) Sett att framstella aminotetralolforeningar.
SE420602B (sv) Sett att framstella pyrazin-3-metoxi-2-karboxamidderivat
SE437771B (sv) Sett att framstella icke-glasartade, sferiska, keramiska mikrokapslar
SE7505595L (sv) Sett att framstella abietamidderivat.
SE427655B (sv) Sett att framstella abietamidderivat
SE7506037L (sv) Sett att framstella stabila kondensationsprodukter
SE7505166L (sv) Sett att framstella elektrodkoks.
SE428471B (sv) Sett att framstella imidazolderivat
SE7508561L (sv) Sett att framstella alfa-azidobensylpenicillin
SE7506038L (sv) Sett att framstella stabila kondensationsprodukter
SE7506036L (sv) Sett att framstella stabila kondensationsprodukter
SE420722B (sv) Sett att framstella benshydryloxi-alkylaminderivat
SE419545B (sv) Sett att framstella metyl-(2-kinoxalinyl-metylen)-karbazat-n?721, n?724-dioxid
SE419991B (sv) Sett att framstella 5-hydroxi-2,3-dihydro-1h-dibenso-tiepino (eller oxepino)-pyrrolderivat
SE412755B (sv) Sett att framstella n-metyl-n-(3,4,5-teimetoxibensyl)-2,3-dimetyl-2,4pentadienamin
SE432937B (sv) Sett att framstella 16alfa,17alfa-acetonidpregnanderivat
SE7513235L (sv) Sett att framstella 1,4-bensodioxaner.